Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02008097 · ClinicalTrials.gov registry record · NA
Clinical Benefits of B-Flow Ultrasound
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT02008097 is a NA study that has completed, run by University of Washington. The registered enrollment target is 180 participants.
The verdict
NCT02008097, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
The goals of this study are to evaluate the efficacy of the B-flow capability on the LOGIQ E9 system in three clinical focus areas. 1. Liver transplant patients: Improved real-time visualization of liver vessels is needed to improve diagnosis and assessment following stenting or angioplasty. 2. Renal artery disease: Improved real-time visualization of the renal arteries would enable a more rapid and accurate assessment of renal artery disease (stenosis, dissection, occlusion, aneurysm) and facilitate follow-up evaluations after renal artery interventions. 3. Pregnancy: We are proposing to use B-flow ultrasound as a way to evaluate placenta perfusion and assay for potential ischemia.
Interventions
- DEVICE GE LOGIQ E9 Ultrasound System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02008097
The ClinicalTrials.gov registry entry for NCT02008097 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GE LOGIQ E9 Ultrasound System is the first listed.
NCT02008097 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02008097 about?
NCT02008097 is a clinical study titled "Clinical Benefits of B-Flow Ultrasound". The goals of this study are to evaluate the efficacy of the B-flow capability on the LOGIQ E9 system in three clinical focus areas. 1. Liver transplant patients: Improved real-time visualization of liver vessels is needed to improve diagnosis and assessment following stenting or angioplasty. 2. Ren...
What is the current status of trial NCT02008097?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2013-10. Estimated completion is 2015-09-01.
What interventions are being tested in trial NCT02008097?
The interventions under investigation include: GE LOGIQ E9 Ultrasound System (DEVICE).
Who is sponsoring clinical trial NCT02008097?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.